CHAIM MANDELBAUM: Open Payments
NPI 1215075908 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,379 in 105 payments from 14 companies in 2025. Trend: 2023 $2,451 · 2024 $1,818 · 2025 $2,379
Food & beverage: $2,379
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 34 | $442 |
| Boston Scientific Corporation | 12 | $391 |
| PFIZER INC. | 9 | $288 |
| Collegium Pharmaceutical, Inc. | 16 | $274 |
| ABBVIE INC. | 10 | $218 |
| Axsome Therapeutics, Inc. | 4 | $204 |
| Azurity Pharmaceuticals, Inc. | 6 | $159 |
| Medtronic, Inc. | 2 | $102 |
| SCILEX PHARMACEUTICALS INC. | 3 | $64 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $54 |
Products named: RELISTOR, WaveWriter Alpha Prime 16, XTAMPZA, Symbravo, NURTEC ODT, HORIZANT, UBRELVY, ZAVZPRET.
Industry payments across NY — which companies pay providers there.
